← Leaderboards
Maia Kipiani
National Center For Tuberculosis And Lung Diseases Jsc(Joint Stock Company)
$180,959
Attributed
$361,918
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $192.1K · FY2019–20$200K$150K$100K$50K$0
'19
'20
Funding mix
By agency
NIH$361,918 · 1
By mechanism
R21$361,918 · 1
Top collaborators
- Matthew James Magee2 shared
Others in their field
Other Emerging Leaders on “Anti-Inflammatory Agents”
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$11,846,278
- James Dale Berry · Brigham And Women'S Hospital$11,146,709
- Avnesh Sinh Thakor · Stanford University$6,829,868
- Mohamed Abdel Mohsen · Wistar Institute$6,609,800
- Guatam Chatnekar · Xequel Bio, Inc.$6,482,734
- Jacob D Estes · Oregon Health & Science University$6,185,511
Research focus
Anti-Inflammatory AgentsAreaAutomobile DrivingBaseBiologicalBiological FactorsBiological MarkersCessation Of LifeChronicClinical PredictorsClinical ResearchCohortCollagenCommunicable DiseasesComorbidityCountryDiagnosisDiagnostic Radiologic ExaminationDisabilityDrug ResistanceEmission-Computed TomographyEnrollmentEnzymesAftercare
Grant awards (2)
Pulmonary impairment after tuberculosis in Georgia: Enhancing clinical research capacity to address the intersection of non-communicablediseases and tuberculosis$169,818
R21 · FY2020 · TW · contact PI
Pulmonary impairment after tuberculosis in Georgia: Enhancing clinical research capacity to address the intersection of non-communicablediseases and tuberculosis$192,100
R21 · FY2019 · TW · contact PI